Semaglutide is the main ingredient in Novo Nordisk’s Wegovy and Ozempic, while tirzepatide is the main ingredient in Eli Lilly’s Zepbound and Mounjaro.
News
Weight-loss surgery more effective than drugs in real world study
January 12, 2026Semaglutide is the main ingredient in Novo Nordisk’s Wegovy and Ozempic, while tirzepatide is the main ingredient in Eli Lilly’s Zepbound and Mounjaro.